| Followers | 253 |
| Posts | 7595 |
| Boards Moderated | 4 |
| Alias Born | 03/16/2014 |
Tuesday, August 18, 2020 11:11:16 AM
Good morning everyone.
Yes I agree 100% with you. And it doesn't help that these guys are super quiet, I tried to see to get some info, but they are not saying anything at all. I told them if they got something put it out dont have people guessing.
As far for the shorting, yes an orca was shorting, probably through interactive brokers and that sucks because if it wasn't for that and them claiming the RSI was too hot and bs, we would be at .10 right now, but this can't make a decision.
So I guess patience is going to have to do, and hopefully the numbers are good, like really good gross and net have to be completely on point
Yes I agree 100% with you. And it doesn't help that these guys are super quiet, I tried to see to get some info, but they are not saying anything at all. I told them if they got something put it out dont have people guessing.
As far for the shorting, yes an orca was shorting, probably through interactive brokers and that sucks because if it wasn't for that and them claiming the RSI was too hot and bs, we would be at .10 right now, but this can't make a decision.
So I guess patience is going to have to do, and hopefully the numbers are good, like really good gross and net have to be completely on point
Recent SBFM News
- Sunshine Biopharma Announces Issuance of U.S. Patent 12,624,066 B2 Covering Novel Coronavirus Treatment Technology • ACCESS Newswire • 05/29/2026 12:00:00 PM
- Sunshine Biopharma Announces Reverse Stock Split to Maintain NASDAQ Listing • ACCESS Newswire • 05/28/2026 01:00:00 PM
- Sunshine Biopharma Receives Canadian Regulatory Approval for Generic Amoxicillin • ACCESS Newswire • 05/21/2026 11:00:00 AM
- Sunshine Biopharma Inc. Announces Closing of up to $18.0 Million Public Offering • ACCESS Newswire • 05/19/2026 04:05:00 PM
- Sunshine Biopharma Inc. Announces Pricing of $6.0 Million Public Offering • ACCESS Newswire • 05/18/2026 04:15:00 PM
- Sunshine Biopharma Reports Fiscal 2025 Revenue of $36.3 Million, a 4.1% Increase Over Prior Year • ACCESS Newswire • 04/06/2026 12:30:00 PM
- Sunshine Biopharma Gains FDA-Equivalent Clearance in Canada for Domperidone to Treat Cancer-related Nausea • ACCESS Newswire • 10/28/2025 11:45:00 AM
- Sunshine Biopharma Launches STD, Acne and Lyme Disease Therapy Doxycycline • ACCESS Newswire • 10/20/2025 11:45:00 AM
- Sunshine Biopharma Launches Cholesterol Fighting Medicine Pravastatin • ACCESS Newswire • 10/16/2025 11:45:00 AM
- Sunshine Biopharma Allocates $5 Million for Investment in Bitcoin as Strategic Reserve Asset to Enhance Treasury Resilience • ACCESS Newswire • 10/14/2025 11:00:00 AM
- Sunshine Biopharma and University of Arizona Develop a Potent New Series of Protease Inhibitors for Treatment of SARS Coronavirus Infections • ACCESS Newswire • 10/09/2025 12:00:00 PM
